These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
114 related items for PubMed ID: 23751143
1. Advanced IgA nephropathy with impaired renal function benefits from losartan treatment in rats. Wang H, Fu W, Jin Z, Wang Y, Yao W, Yin P, Peng W. Ren Fail; 2013 Jul; 35(6):812-8. PubMed ID: 23751143 [Abstract] [Full Text] [Related]
2. Losartan alleviates renal fibrosis by down-regulating HIF-1α and up-regulating MMP-9/TIMP-1 in rats with 5/6 nephrectomy. Fu W, Wang Y, Jin Z, Wang H, Cheng W, Zhou H, Yin P, Peng W. Ren Fail; 2012 Jul; 34(10):1297-304. PubMed ID: 23006043 [Abstract] [Full Text] [Related]
3. Additive effect of PPAR-γ agonist and ARB in treatment of experimental IgA nephropathy. Lai KN, Chan LY, Guo H, Tang SC, Leung JC. Pediatr Nephrol; 2011 Feb; 26(2):257-66. PubMed ID: 21125406 [Abstract] [Full Text] [Related]
7. Rapamycin slows IgA nephropathy progression in the rat. Tian J, Wang Y, Zhou X, Li Y, Wang C, Li J, Li R. Am J Nephrol; 2014 Feb; 39(3):218-29. PubMed ID: 24603476 [Abstract] [Full Text] [Related]
8. [Dilingdan Decoction prevents renal interstitial fibrosis in a rat model of unilateral ureteral obstruction]. Huan HD, Zhang JH, Zheng SR, Meng WW, Zhang JL. Zhong Xi Yi Jie He Xue Bao; 2008 May; 6(5):493-7. PubMed ID: 18471414 [Abstract] [Full Text] [Related]
9. [Effect of telmisartan on tubulointerstitial injury and expression of PPARγ in rat renal tissue of IgA nephropathy model]. Xing L, Bai L, Yu CY, Xie RJ. Zhonghua Yi Xue Za Zhi; 2010 Nov 02; 90(40):2860-3. PubMed ID: 21162800 [Abstract] [Full Text] [Related]
12. [Effects of losartan, ramipril and their combination on left ventricular remodeling and function in spontaneous hypertensive rats]. Xu R, Zhang Y, Zhang M, Li XC, Cai H, Chen WQ, Zhu H, Ge ZM, Zhang W. Zhonghua Yi Xue Za Zhi; 2005 Nov 30; 85(45):3199-204. PubMed ID: 16405840 [Abstract] [Full Text] [Related]
13. Reduced progression of adriamycin nephropathy in spontaneously hypertensive rats treated by losartan. Mihailovic-Stanojevic N, Jovovic D, Miloradovic Z, Grujic-Milanovic J, Jerkic M, Markovic-Lipkovski J. Nephrol Dial Transplant; 2009 Apr 30; 24(4):1142-50. PubMed ID: 18987260 [Abstract] [Full Text] [Related]
14. Salt-induced downregulation of renal aquaporins is prevented by losartan. Della Penna SL, Cao G, Fellet A, Balaszczuk AM, Zotta E, Cerrudo C, Pandolfo M, Toblli JE, Fernández BE, Rosón MI. Regul Pept; 2012 Aug 20; 177(1-3):85-91. PubMed ID: 22587908 [Abstract] [Full Text] [Related]
15. Pathological regression by angiotensin II type 1 receptor blockade in patients with mesangial proliferative glomerulonephritis. Ohtake T, Oka M, Maesato K, Mano T, Ikee R, Moriya H, Kobayashi S. Hypertens Res; 2008 Mar 20; 31(3):387-94. PubMed ID: 18497456 [Abstract] [Full Text] [Related]
16. Effect of losartan and amlodipine on proteinuria and transforming growth factor-beta1 in patients with IgA nephropathy. Park HC, Xu ZG, Choi S, Goo YS, Kang SW, Choi KH, Ha SK, Lee HY, Han DS. Nephrol Dial Transplant; 2003 Jun 20; 18(6):1115-21. PubMed ID: 12748343 [Abstract] [Full Text] [Related]